Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a sophisticated tool designed to enhance the success rates of IVF by identifying embryos free from aneuploidy before transfer. This innovative approach aims to reduce the likelihood of selecting an aneuploid embryo, thereby potentially decreasing the time to pregnancy, lowering miscarriage rates, and offering a cost-effective solution when multiple embryos are available. Endorsed by the American Society of Reproductive Medicine, PGT-A supports the strategy of single embryo transfer, maintaining high pregnancy rates while minimizing the risks associated with multiple gestations.